EQUITY (DEFICIT) (Tables)

9 Months Ended

Sep. 30, 2015

Schedule Of Common Stock, Capital Shares Reserved For Future Issuance [Table Text Block]

The Company is authorized to issue up to 147,397,390 shares of common stock. At September 30, 2015, shares of common stock reserved for future issuance are as follows:

Stock options outstanding		1,231,500
Warrants outstanding		100,000
Stock options available for grant		2,309,250
Restricted shares		336,847
		3,977,597

Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]

The stock-based compensation expense recorded by the Company for the nine months ended September 30, 2015 and 2014, with respect to awards under the Company’s stock plans are as follows:

	2015		2014
Research and development	$	-	$	995
General and administrative		-		-
Total employee stock-based compensation	$	-	$	995

Schedule Of Share Based Compensation Stock Options Activity [Table Text Block]

The following is a summary of the Company’s stock option activity:

					Weighted
			Weighted		Average
			Average		Remaining		Aggregate
			Exercise		Contractual		Intrinsic
	Shares		Price		Term		Value

Outstanding at January 1, 2015		1,381,500	$	0.91
Granted		-		-
Exercised		-		-
Forfeited		(150,000)		0.10
Outstanding at September 30, 2015		1,231,500	$	1.01		3.55 years	$	75,480
Options Exercisable at September 30, 2015		1,231,500	$	1.01		3.55 years	$	75,480

Schedule Of Share Based Compensation Warrant Activities [Table Text Block]

The following is a summary of the Company’s warrant activity:

					Weighted
			Weighted		Average
			Average		Remaining		Aggregate
			Exercise		Contractual		Intrinsic
	Shares		Price		Term		Value

Outstanding at January 1, 2015		350,000	$	0.37
Granted		-
Forfeited		(250,000)		0.40
Outstanding at September 30, 2015		100,000		0.30		1.06 years	$	12,000
Exercisable at September 30, 2015		100,000		0.30		1.06 years	$	12,000

ONCOVISTA INNOVATIVE THERAPIES, INC 10-Q